These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Heparin-binding transforming growth factor alpha-Pseudomonas exotoxin A. A heparan sulfate-modulated recombinant toxin cytotoxic to cancer cells and proliferating smooth muscle cells. Mesri EA; Kreitman RJ; Fu YM; Epstein SE; Pastan I J Biol Chem; 1993 Mar; 268(7):4853-62. PubMed ID: 8444864 [TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity. Sarosdy MF; Hutzler DH; Yee D; von Hoff DD J Urol; 1993 Dec; 150(6):1950-5. PubMed ID: 8230543 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. Kunwar S; Pai LH; Pastan I J Neurosurg; 1993 Oct; 79(4):569-76. PubMed ID: 7692018 [TBL] [Abstract][Full Text] [Related]
11. Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer. Goldberg MR; Heimbrook DC; Russo P; Sarosdy MF; Greenberg RE; Giantonio BJ; Linehan WM; Walther M; Fisher HA; Messing E Clin Cancer Res; 1995 Jan; 1(1):57-61. PubMed ID: 9815887 [TBL] [Abstract][Full Text] [Related]
12. Biological activity of a transforming growth factor-alpha--Pseudomonas exotoxin fusion protein in vitro and in vivo. Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A J Ind Microbiol; 1991 Apr; 7(3):203-7. PubMed ID: 1367127 [TBL] [Abstract][Full Text] [Related]
13. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells. Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623 [TBL] [Abstract][Full Text] [Related]
14. Small chimeric toxins containing only transforming growth factor alpha and domain III of Pseudomonas exotoxin with good antitumor activity in mice. Kihara A; Pastan I Cancer Res; 1994 Oct; 54(19):5154-9. PubMed ID: 7923133 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of recombinant TGFalpha-PE40 on neointimal proliferation after arterial balloon injury. Wang B; Xu YH; Li YL; Zhang GY; Jiang WL; Rui YC; Wu ZG Acta Pharmacol Sin; 2001 Jan; 22(1):15-20. PubMed ID: 11730555 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF alpha-Pseudomonas exotoxin. Fu YM; Mesri EA; Yu ZX; Kreitman RJ; Pastan I; Epstein SE Cardiovasc Res; 1993 Sep; 27(9):1691-7. PubMed ID: 8287449 [TBL] [Abstract][Full Text] [Related]
17. TGF alpha-PE40 inhibits non-small cell lung cancer growth. Draoui M; Siegall CB; FitzGerald D; Pastan I; Moody TW Life Sci; 1994; 54(7):445-53. PubMed ID: 8309347 [TBL] [Abstract][Full Text] [Related]
18. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo. Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895 [TBL] [Abstract][Full Text] [Related]
19. A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer. Theuer CP; FitzGerald DJ; Pastan I J Urol; 1993 Jun; 149(6):1626-32. PubMed ID: 8501821 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effect of a fusion protein from transforming growth factor alpha and Pseudomonas exotoxin on rat and human bladder carcinoma cells in vitro. Kameyama S; Kawamata H; Pastan I; Oyasu R J Cancer Res Clin Oncol; 1994; 120(9):507-12. PubMed ID: 8045915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]